Related references
Note: Only part of the references are listed.Biomarkers for the effects of cannabis and THC in healthy volunteers
Lineke Zuurman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers
L. Zuurman et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Can recreational doses of THC produce significant dopamine release in the human striatum?
Paul R. A. Stokes et al.
NEUROIMAGE (2009)
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Matthijs G. Bossong et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette
Arthur L. Brody et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Positron Emission Tomography Imaging of Amphetamine-Induced Dopamine Release in the Human Cortex: A Comparative Evaluation of the High Affinity Dopamine D2/3 Radiotracers [11C]FLB 457 and [11C]Fallypride
Rajesh Narendran et al.
SYNAPSE (2009)
Effect of intrapulmonary tetrahydrocannabinol administration in humans
L. Zuurman et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Modelling of the concentration-effect relationship of THC on central nervous system parameters and heart rate - insight into its mechanisms of action and a tool for clinical research and development of cannabinoids
A. Strougo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans
Deepak Cyril D'Souza et al.
PSYCHOPHARMACOLOGY (2008)
Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans
Vanessa L. Cropley et al.
SYNAPSE (2008)
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha(2,3) subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers
S. L. de Haas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
The influence of alcohol on basic motoric and cognitive disinhibition
A. K. Rose et al.
ALCOHOL AND ALCOHOLISM (2007)
Heterogeneous effects of alcohol on dopamine release in the striatum: A PET study
Karmen K. Yoder et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
An experimental study of catechol-O-methyltransferase Val158Met moderation of Δ-9-tetrahydrocannabinol-induced effects on psychosis and cognition
Cecile Henquet et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The acute effects of cannabinoids on memory in humans: a review
Mohini Ranganathan et al.
PSYCHOPHARMACOLOGY (2006)
Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs
Steven R. Laviolette et al.
JOURNAL OF NEUROSCIENCE (2006)
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans
P Riccardi et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Dopaminergic enhancement of cognitive function
Mitul A. Mehta et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol
RM Kessler et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Reduced stroop interference for opponent colors may be due to input factors:: Evidence from individual differences and a neural network simulation
B Laeng et al.
JOURNAL OF EXPERIMENTAL PSYCHOLOGY-HUMAN PERCEPTION AND PERFORMANCE (2005)
Endocannabinoid signaling system and brain reward: Emphasis on dopamine
EL Gardner
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease
NI Bohnen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
C Henquet et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity
J van der Post et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Marijuana and cannabinoid regulation of brain reward circuits
CR Lupica et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Smoking-induced ventral striatum dopamine release
AL Brody et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Cannabinoid physiology and pharmacology: 30 years of progress
AC Howlett et al.
NEUROPHARMACOLOGY (2004)
Multicentre performance evaluation of the E170 module for MODULAR ANALYTICS
C Bieglmayer et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients
JP van der Post et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Alcohol promotes dopamine release in the human nucleus accumbens
I Boileau et al.
SYNAPSE (2003)
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms - a review of recent preclinical data
G Tanda et al.
PSYCHOPHARMACOLOGY (2003)
Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension
MJB Kemme et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum
D Martinez et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Biomarkers for the effects of benzodiazepines in healthy volunteers
SJ de Visser et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
μ-Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man
N Hagelberg et al.
SYNAPSE (2002)
Saccadic peak velocity and EEG as end-points for a serotonergic challenge test
HJ Gijsman et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2002)
How does drug and alcohol misuse develop among people with psychotic illness? A literature review
P Phillips et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2001)
Biomarkers for the effects of antipsychotic drugs in healthy volunteers
SJ de Visser et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
WC Drevets et al.
BIOLOGICAL PSYCHIATRY (2001)
Role of dopamine in learning and memory - Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease
J Kulisevsky
DRUGS & AGING (2000)
Share Paper
